oxybutynin has been researched along with levodopa in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Boroojerdi, B; Giladi, N; Surmann, E | 1 |
| Bachmann, CG; Berg, D; Berkels, R; Grieger, F; Hofmann, WE; Lauterbach, T; Schollmayer, E; Stiasny-Kolster, K | 1 |
| Berkels, R; Grieger, F; Lauterbach, T; Lorenzl, S; Sieb, JP; Themann, P; Warnecke, T | 1 |
| Asgharnejad, M; Barone, P; Bauer, L; Dohin, E; Hauser, RA; Slawek, J; Surmann, E | 1 |
| Al-Shar'i, N; Athamneh, T; Obaidat, R; Tashtoush, B | 1 |
| Greenberg, I; Levy, HV; Sintov, AC | 1 |
| D'Elia, A; Imbriani, P; Pisani, A; Schirinzi, T | 1 |
| Fukuda, K; Hirano, M; Isono, C; Kusunoki, S; Nakamura, Y; Ueno, S | 1 |
| Fukuta, H; Hasegawa, K; Hattori, N; Mochizuki, H; Nomoto, M; Okawa, K; Terahara, T; Uchida, E | 1 |
| Ann Natividad, J; Chaudhuri, KR; Chung-Faye, G; Lau, YH; Leta, V; Metta, V; Parry, M; Rukavina, K | 1 |
4 trial(s) available for oxybutynin and levodopa
| Article | Year |
|---|---|
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease.
Topics: Adolescent; Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Survival Analysis; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2013 |
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Germany; Humans; Levodopa; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Self Administration; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2013 |
Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Caregivers; Cross-Sectional Studies; Dopamine Agonists; Female; Germany; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physicians; Pilot Projects; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Young Adult | 2015 |
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Apathy; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2016 |
9 other study(ies) available for oxybutynin and levodopa
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches.
Topics: Acrylates; Administration, Cutaneous; Animals; Antiparkinson Agents; beta-Cyclodextrins; Crystallography, X-Ray; Drug Combinations; Drug Stability; Levodopa; Male; Polysaccharides, Bacterial; Rats; Rats, Sprague-Dawley; Sequestering Agents; Transdermal Patch; X-Ray Diffraction | 2018 |
Continuous Transdermal Delivery of L-DOPA Based on a Self-Assembling Nanomicellar System.
Topics: Administration, Cutaneous; Animals; Antiparkinson Agents; Carbidopa; Drug Carriers; Drug Combinations; Drug Liberation; Levodopa; Male; Micelles; Nanoparticles; Permeability; Rabbits; Rats, Sprague-Dawley; Skin Absorption; Surface Properties; Swine; Transdermal Patch | 2017 |
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report.
Topics: Aged; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Male; Parkinson Disease; Receptors, Dopamine; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2017 |
Effects of the rotigotine transdermal patch versus oral levodopa on swallowing in patients with Parkinson's disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antiparkinson Agents; Deglutition; Dopamine Agonists; Female; Humans; Levodopa; Male; Parkinson Disease; Retrospective Studies; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2019 |
Long-term study of ropinirole patch in Parkinson's disease patients with/without basal l-dopa.
Topics: Adult; Aged; Dopamine Agonists; Drug Substitution; Female; Humans; Indoles; Levodopa; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Severity of Illness Index; Transdermal Patch | 2021 |
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson's disease.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Levodopa; Longitudinal Studies; Parkinson Disease; Quality of Life; Retrospective Studies; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2022 |